Predict your next investment

Kaiser Permanente company logo
Corporation
HEALTHCARE | Medical Facilities & Services / Hospitals
kaiserpermanente.org

See what CB Insights has to offer

Investments

12

Portfolio Exits

1

Partners & Customers

10

About Kaiser Permanente

Kaiser Permanente is committed to helping shape the future of health care. The company is recognized as one of America's leading health care providers and not-for-profit health plans. Founded in 1945, its mission is to provide high-quality, affordable health care services and to improve the health of our members and the communities served. Care for members and patients is focused on their total health and guided by their personal physicians, specialists and team of caregivers.

Kaiser Permanente Headquarter Location

1 Kaiser Plaza

Oakland, California, 94612,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Kaiser Permanente

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Kaiser Permanente in 1 Expert Collection, including Health Plans & Benefits Management.

H

Health Plans & Benefits Management

698 items

Companies developing or offering digital platforms and services, including online insurance marketplaces, data analytics for claims adjustment, benefits administration, and payments systems, that help make private health insurance more affordable, navigable, or transparent.

Kaiser Permanente Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Kaiser Permanente Rank

Research containing Kaiser Permanente

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Kaiser Permanente in 2 CB Insights research briefs, most recently on Oct 28, 2019.

Latest Kaiser Permanente News

Vaccines Are Less Effective at Protecting Against Severe COVID-19 in Immunocompromised Adults

Dec 1, 2021

Susceptible people should receive a 3-dose vaccine series and a booster. New real-world evidence gathered by the U.S. Centers for Disease Control and Prevention (CDC) shows that COVID-19 vaccines are less effective at protecting against COVID-19-associated hospitalizations in people who are immunocompromised. In general, immunocompromised individuals are at an increased risk for severe COVID-19 outcomes. “These findings indicate that while two-doses of mRNA COVID-19 vaccines are beneficial in immunocompromised individuals, they are significantly less protected from severe disease than people with normal immune systems,” said study lead author Peter Embí, M.D., M.S., Regenstrief Institute president and chief executive officer and associate dean for informatics and health services research at the Indiana University School of Medicine. “Since they are less protected after a two-dose series, those who are immunocompromised should receive an additional dose and a booster, take additional precautions like masking when in public, and, if they get infected, they should seek treatment with proven therapies that can protect against progression to severe disease and the need for hospitalization.” The research team gathered data from more than 89,000 hospitalizations across nine states, making this the largest study of its kind evaluating COVID-19 vaccine effectiveness among immunocompromised people. Data analyses showed that mRNA vaccines (manufactured by Pfizer and Moderna) were 90 percent effective at protecting against COVID-related hospitalization in immunocompetent individuals, whereas they were only 77 percent effective in those with suppressed immunity due to a range of health conditions. The differences were similar across age groups. However, the effectiveness varied greatly among immunocompromised subgroups. For example, it was lower in organ or stem cell transplant patients and better in people with rheumatologic or inflammatory disorders. The data came from the VISION Network, a collaboration between the CDC and seven organizations with integrated medical, laboratory, and vaccination records. The network was established to assess the effectiveness of COVID-19 vaccines. In addition to Regenstrief Institute, other members are Columbia University Irving Medical Center, HealthPartners, Intermountain Healthcare, Kaiser Permanente Northern California, Kaiser Permanente Northwest, and University of Colorado. Dr. Embí is the first author. Other authors from Regenstrief and IU are Shaun Grannis, M.D., M.S. ; Brian Dixon, PhD, MPA; William F. Fadel, PhD and Nimish R. Valvi, DrPH. Other authors on the paper are Matthew E. Levy, PhD, of Westat; Allison L. Naleway, PhD, of Kaiser Permanente Northwest; Palak Patel, MBBS, of the CDC COVID-19 Response Team; Manjusha Gaglani, MBBS, of Texas A&M University; Karthik Natarajan, PhD, of Columbia University and New York Presbyterian Hospital; Kristin Dascomb, M.D., PhD, of Intermountain Healthcare; Toan C. Ong, PhD, of University of Colorado; Nicola P. Klein, M.D., PhD, of Kaiser Permanente Northern California; I-Chia Liao, MPH, of Texas A&M University; Jungmi Han of Columbia University; Edward Stenehjem, M.D., of Intermountain Healthcare; Margaret M. Dunne, MSc, of Westat; Ned Lewis, MPH, of Kaiser Permanente Northern California; Stephanie A. Irving, MHS, of Kaiser Permanente Northwest; Suchitra Rao, MBBS, of University of Colorado; Charlene McEvoy, M.D., of HealthPartners Institute; Catherine H. Bozio, PhD, of the CDC COVID-19 Response Team; Kempapura Murthy, MBBS, of Texas A&M University; Nancy Grisel, MPP, of Intermountain Healthcare; Duck-Hye Yang, PhD, of Westat; Kristin Goddard, MPH, of Kaiser Permanente Northern California; Anupam B. Kharbanda, M.D., of Children’s Minnesota; Sue Reynolds, PhD, of the CDC COVID-19 Response Team; Chandni Raiyani, MPH, of Intermountain Healthcare; Julie Arndorfer, MPH, of Intermountain Healthcare; Elizabeth A. Rowley, DrPH, of Westate; Bruce Fireman, M.A., of Kaiser Permanente Northern California; Jill Ferdinands, PhD, of the CDC COVID-19 Response Team; Sarah W. Ball, ScD, of Westat; Ousseny Zerbo, PhD. Of Kaiser Permanente Northern California; Eric P. Griggs, MPH, of the CDC COVID-19 Response Team; Patrick K. Mitchell, ScD, of Westate; Rachael M. Porter, MPH, of the CDC COVID-19 Response Team; Salome A. Kiduko, MPH, of Westat; Lenee Blanton, MPH, of the CDC COVID-19 Response Team; Yan Zhuang, PhD of Westat; Andrea Steffens, MPH, of the CDC COVID-19 Response Team; Sarah E. Reese, PhD, of Westat; Natalie Olson, MPH, of the CDC COVID-19 Response Team; Jeremiah Williams, MPH, of the CDC COVID-19 Response Team; Monica Dickerson, MPH, of the CDC COVID-19 Response Team; Meredith McMorrow, M.D. of the CDC COVID-19 Response Team; Stephanie J. Schrag, DPhil, of the CDC COVID-19 Response Team; Jennifer R. Verani, M.D. of the CDC COVID-19 Response Team; Alicia M. Fry, M.D. of the CDC COVID-19 Response Team; Eduardo Azziz-Baumgartner, M.D. of the CDC COVID-19 Response Team; Michelle A. Barron, M.D., of the University of Colorado; Mark G. Thompson, PhD, of the CDC COVID-19 Response Team and Malini B. DeSilva, M.D. of HealthPartners Institute.

Kaiser Permanente Investments

12 Investments

Kaiser Permanente has made 12 investments. Their latest investment was in NOCD as part of their Series B on September 9, 2021.

CBI Logo

Kaiser Permanente Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/21/2021

Series B

NOCD

$33M

Yes

3

7/9/2021

Series D

Spinny

$108M

Yes

7

5/10/2021

Private Equity

ETHealthcare

$100M

Yes

4

4/30/2021

Series C

Subscribe to see more

$99M

Subscribe to see more

10

1/19/2021

Series E

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/21/2021

7/9/2021

5/10/2021

4/30/2021

1/19/2021

Round

Series B

Series D

Private Equity

Series C

Series E

Company

NOCD

Spinny

ETHealthcare

Subscribe to see more

Subscribe to see more

Amount

$33M

$108M

$100M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

7

4

10

10

Kaiser Permanente Portfolio Exits

1 Portfolio Exit

Kaiser Permanente has 1 portfolio exit. Their latest portfolio exit was Archimedes on January 09, 2014.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/9/2014

Divestiture

1

Date

1/9/2014

Exit

Divestiture

Companies

Valuation

Acquirer

Sources

1

Kaiser Permanente Acquisitions

1 Acquisition

Kaiser Permanente acquired 1 company. Their latest acquisition was Group Health Cooperative on December 04, 2015.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

12/4/2015

$991

Acquired

3

Date

12/4/2015

Investment Stage

Companies

Valuation

$991

Total Funding

Note

Acquired

Sources

3

Kaiser Permanente Partners & Customers

10 Partners and customers

Kaiser Permanente has 10 strategic partners and customers. Kaiser Permanente recently partnered with Local Initiatives Support on October 10, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

10/14/2021

Partner

Local Initiatives Support

United States

About Kaiser Permanente Home Placing a High Priority on Community Health

The partnership between Kaiser Permanente and LISC focuses on three main objectives to aid small businesses : .

1

9/16/2021

Partner

Silver Diner

United States

Silver Diner Partners with Kaiser and Health Officials to Host Mobile COVID Vaccination Units

Kaiser has partnered with Silver Diner on health and wellness programs for the past 15 years .

1

7/11/2021

Vendor

Tri-City Medical Center

United States

Tri-City Expands Service to Kaiser Patients

`` This agreement expands Kaiser Permanente 's 24-year relationship with Tri-City Medical Center , '' said Jane Finley , senior vice president and area manager for Kaiser Permanente .

1

6/30/2021

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

6/1/2021

Vendor

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

10/14/2021

9/16/2021

7/11/2021

6/30/2021

6/1/2021

Type

Partner

Partner

Vendor

Partner

Vendor

Business Partner

Local Initiatives Support

Silver Diner

Tri-City Medical Center

Country

United States

United States

United States

Subscribe to see more

Subscribe to see more

News Snippet

About Kaiser Permanente Home Placing a High Priority on Community Health

The partnership between Kaiser Permanente and LISC focuses on three main objectives to aid small businesses : .

Silver Diner Partners with Kaiser and Health Officials to Host Mobile COVID Vaccination Units

Kaiser has partnered with Silver Diner on health and wellness programs for the past 15 years .

Tri-City Expands Service to Kaiser Patients

`` This agreement expands Kaiser Permanente 's 24-year relationship with Tri-City Medical Center , '' said Jane Finley , senior vice president and area manager for Kaiser Permanente .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

1

1

10

10

Kaiser Permanente Team

121 Team Members

Kaiser Permanente has 121 team members, including current Chief Executive Officer, Senior Vice President, Kimberly Menzel.

Name

Work History

Title

Status

Kimberly Menzel

Chief Executive Officer, Senior Vice President

Current

Sandy Sharon

Senior Vice President

Current

Stephen Tarnoff

Chief Executive Officer, President

Current

Robert Alger

President, Senior Vice President

Current

Anthony A. Barrueta

President, Senior Vice President

Current

Name

Kimberly Menzel

Sandy Sharon

Stephen Tarnoff

Robert Alger

Anthony A. Barrueta

Work History

Title

Chief Executive Officer, Senior Vice President

Senior Vice President

Chief Executive Officer, President

President, Senior Vice President

President, Senior Vice President

Status

Current

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.